Increasing Liquid Biopsy Sensitivity to the Next Level: Usability of Minimal Residual Disease Detection by Longitudinal Genomic Fusion Tracing Using Specific Digital Droplet PCR (ddpcr) in Non-Small Cell Lung Cancer (NSCLC) Treated with Immune Checkpoint Inhibition (ICI) Plus /- Chemotherapy